Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27,767,902
-
Number of holders
-
146
-
Total 13F shares, excl. options
-
13,334,548
-
Shares change
-
+225,989
-
Total reported value, excl. options
-
$446,581,457
-
Value change
-
+$14,267,822
-
Put/Call ratio
-
0%
-
Number of buys
-
79
-
Number of sells
-
52
-
Price
-
$33.50
Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q4 2016
As of 31 Dec 2016 ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) had 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,334,548 shares of stock of the company.
Largest 10 holders included BlackRock Fund Advisors, Krensavage Asset Management, LLC, GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, FIRST MANHATTAN CO, and BlackRock Institutional Trust Company, N.A..
This table shows 165 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.